Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

18.24
+0.04500.25%
Post-market: 18.21-0.0299-0.16%16:58 EDT
Volume:2.48M
Turnover:45.32M
Market Cap:1.79B
PE:-7.04
High:18.64
Open:18.45
Low:18.02
Close:18.20
Loading ...

Sarepta initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
17 Jun

US STOCKS-Equities rise as oil prices ease on truce hopes

Reuters
·
17 Jun

Sarepta price target lowered to $54 from $125 at Jefferies

TIPRANKS
·
17 Jun

BofA expects no changes for Regenxbio regimen after competitor safety issue

TIPRANKS
·
17 Jun

Cantor Fitzgerald Downgrades Sarepta Therapeutics to Neutral From Overweight, $20 Price Target; Shares Plunge

MT Newswires Live
·
17 Jun

Sarepta patient death likely to hurt commercial uptake, says Cantor Fitzgerald

TIPRANKS
·
17 Jun

Sarepta Therapeutics (SRPT) Gets a Buy from UBS

TIPRANKS
·
17 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Eaton, Roku, PayPal

Reuters
·
16 Jun

Top Midday Stories: Equity Markets Rise on Hopes of Containment of Israel-Iran Hostilities; Meta to Introduce Ads on WhatsApp

MT Newswires Live
·
16 Jun

Needham cuts Sarepta target, says Elevidys removal unlikely

TIPRANKS
·
16 Jun

Sarepta Therapeutics Down Over 45%, on Track for Lowest Close Since June 2016 -- Data Talk

Dow Jones
·
16 Jun

Sarepta Therapeutics: Buy Rating Maintained Despite Elevidys Setback and Revised FY:25 Sales Outlook

TIPRANKS
·
16 Jun

Sarepta Therapeutics Inc : Needham Cuts Target Price to $50 From $125

THOMSON REUTERS
·
16 Jun

BofA downgrades Sarepta to Neutral after second death of patient taking Elevidys

TIPRANKS
·
16 Jun

Sarepta Therapeutics Shares Hit Lowest Level in Near Nine Years, Last Down 46%

THOMSON REUTERS
·
16 Jun

Stock Track | Sarepta Therapeutics Plummets 43% After Second Fatal Case Linked to Gene Therapy

Stock Track
·
16 Jun

Sarepta Therapeutics Shares Down 42.2% After Co Reports Second Case of Liver Failure Death After Its Gene Therapy Treatment

THOMSON REUTERS
·
16 Jun

Sector Update: Health Care Stocks Flat to Higher Premarket Monday

MT Newswires Live
·
16 Jun

Sarepta Therapeutics Exec Says Co Has Suspended Its Revenue Guidance and Will Update It During Its Second Quarter Results

THOMSON REUTERS
·
16 Jun

Sarepta Therapeutics Exec Says Patient Who Died After Its Gene Therapy Treatment Was 15 Years Old

THOMSON REUTERS
·
16 Jun